Aster Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-52,442
Closed -$4.15M 1220
2025
Q2
$4.15M Buy
52,442
+38,444
+275% +$3.06M 0.94% 21
2025
Q1
$1.29M Buy
+13,998
New +$1.31M 0.24% 113
2024
Q4
Sell
-10,891
Closed -$1.24M 1364
2024
Q3
$1.24M Buy
+10,891
New +$1.29M 0.27% 90

Other funds holding MRK

Aster Capital Management's MRK Position: Q3 2025 in Review

Aster Capital Management sold out of Merck (MRK) in Q3 2025, closing a stake of 52,442 shares — an estimated $4.15M sold.

Aster Capital Management first reported a position in MRK in Q3 2024 and held it in 3 quarters. The position peaked at $4.15M in Q2 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Aster Capital Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Aster Capital Management sold 52,442 Merck shares in Q3 2025, an estimated $4.15M.
  • Aster Capital Management first reported a position in Merck in Q3 2024 and held it in 3 quarters.
  • Aster Capital Management's Merck position peaked at $4.15M in Q2 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Aster Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.